Skip to main content

Hercules Capital — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

67
Companies
$9.1B
Total invested
$117.8M
Avg. check
33
Industries
Biotechnology 12Therapeutics 6Health Care 6Automotive 3Medical 3Biopharma 3+27 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 4967 of 67
RumbleON
November 2024

RumbleON provides an e-commerce platform that facilitates to sell, buy, trade pre-owned recreation vehicles.

Automotive · Irving$10.0M Post Ipo Equity
SynOx Therapeutics
October 2024

SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors.

Biotechnology · Dublin$92.0M Series B
Carwow
July 2024

Carwow is an online car marketplace that connects customers, automotive brands and car dealers.

Automotive · London$52.0M Series Unknown
Gritstone bio
April 2024

Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.

Biotechnology · Emeryville$32.5M Post Ipo Equity
Better Therapeutics
January 2024

Better Therapeutics develops prescription software for treating cardiometabolic diseases.

Artificial Intelligence (AI) · San Francisco$250K Post Ipo Equity
AmplifyBio
November 2023

AmplifyBio is a biotechnology company that develops and advances treatments and cures for disease via cutting-edge technology and research.

Biotechnology · West Jefferson$49.8M Series Unknown
Alladapt Immunotherapeutics
August 2022

Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy.

Biotechnology · Menlo Park$50.0M Debt Financing
ZeroFox
August 2022

ZeroFox provides external cybersecurity solutions to help organizations identify, manage, and mitigate social media-based cyber threats.

Cyber Security · Baltimore$170.0M Post Ipo Equity
Locus Biosciences
May 2022

Locus Biosciences develops CRISPR-engineered precision antibacterial platform designed to revolutionize the treatment of bacterial disease.

Biopharma · Morrisville$35.0M Series B
Convoy
April 2022

Convoy is a digital freight network that moves truckloads and design solutions that address supply chain inefficiencies.

Freight Service · Seattle$250.0M Debt Financing
Esme Learning Solutions
February 2022

Esme Learning is transforming the world's workforce for the Fourth Industrial Revolution using AI.

Artificial Intelligence (AI) · Newton$15.0M Series Unknown
Lucira Health
February 2022

Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.

Biotechnology · Emeryville$80.0M Post Ipo Debt
NorthSea Therapeutics
December 2021

NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics.

Biotechnology · Naarden$80.0M Series C
908 Devices
November 2021

908devices manufactures battery-operated, hand-held chemical detection tools used in mass spectrometry.

Battery · Boston$101.0M Post Ipo Equity
3Gtms
September 2021

3GTMS provides transportation management system software for shippers, brokers, and logistics service providers.

Automotive · Columbus$15.0M Private Equity
Sio Gene Therapies
February 2020

Sio Gene Therapies is a clinical-stage biopharmaceutical company.

Biopharma · New York$74.7M Post Ipo Equity
Sebacia
August 2019

Sebacia is a commercial-stage dermatology company that develops an alternative to the topical and systemic drugs for the treatment of acne.

Biotechnology · Duluth$10.0M Series Unknown
Urovant Sciences
February 2019

Urovant Sciences is a global biopharmaceutical company focused on developing novel therapies for urologic conditions.

Biopharma · Basel$100.0M Debt Financing
Gamma Medica
October 2014

Gamma Medica offers LumaGEM® MBI System, an FDA-cleared dual-headed digital imaging system.

Biotechnology · Salem$6.5M Debt Financing

Where Hercules Capital invests

Biotechnology12
Therapeutics6
Health Care6
Automotive3
Medical3
Biopharma3

About Hercules Capital's portfolio

How many companies has Hercules Capital invested in?

Hercules Capital has invested in 67 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Hercules Capital invest in?

Hercules Capital's top investment sectors include Biotechnology, Therapeutics, Health Care, Automotive, Medical. The firm invests across 33 different industry categories.

What is Hercules Capital's largest investment?

Among tracked funding rounds, Convoy received $250.0M in a Debt Financing round. Hercules Capital's total known invested capital is $9.1B.

What is the average investment size for Hercules Capital?

Hercules Capital's average investment size is $117.8M across its portfolio of 67 companies.

What are Hercules Capital's most recent investments?

Recent Hercules Capital portfolio additions include RumbleON, SynOx Therapeutics, Carwow, Gritstone bio, Better Therapeutics. These companies were founded in 2020 or later.

Reach the founders behind these 67 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →